Filing summary
Issuer and period: The filing is Dr Pepper Snapple Group, Inc.’s unaudited Form 10-Q for the quarter ended March 31, 2015. Although the request identifies Keurig Dr Pepper Inc., the filing itself names Dr Pepper Snapple Group, Inc. as the registrant; verify the issuer and historical corporate context before associating these results with present-day KDP.
Business: The company describes itself as an integrated beverage brand owner, manufacturer and distributor operating in the U.S., Canada, Mexico and other Latin American markets. Its three segments are Beverage Concentrates, Packaged Beverages and Latin America Beverages. Beverage sales are seasonal and generally higher in warmer months.
Financial performance
| Metric | Q1 2015 | Q1 2014 | Change |
|---|---|---|---|
| Net sales | $1.451 billion | $1.398 billion | +4% |
| Gross profit / margin | $849 million / 58.5% | $844 million / 60.4% | Profit +1%; margin down 1.9 percentage points |
| Operating income / margin | $270 million / 18.6% | $260 million / 18.6% | +4% |
| Net income | $157 million | $155 million | +1% |
| Diluted EPS | $0.81 | $0.78 | +4% |
| Operating cash flow | $101 million | $129 million | Down $28 million |
| Cash and cash equivalents, quarter-end | $93 million | $237 million at Dec. 31, 2014 | Down $144 million |
- Sales growth reflected higher branded volumes and favorable segment and product mix, partly offset by $18 million of unfavorable foreign-currency translation. Bottler case sales rose 3% overall; U.S. and Canada volume rose 2%, while Mexico and the Caribbean rose 13%.
- Gross margin fell mainly because of unfavorable product and segment mix and a less favorable commodity-derivative mark-to-market comparison. The filing cites a 1.2-point effect from mix and a 1.0-point effect from commodity mark-to-market, partly offset by productivity improvements (+0.5 point) and net pricing (+0.1 point). Commodity contracts produced $2 million of unrealized losses versus $12 million of unrealized gains a year earlier.
- Segment sales and segment operating profit (SOP): Beverage Concentrates, $285 million sales and $183 million SOP; Packaged Beverages, $1.053 billion and $141 million; Latin America Beverages, $113 million and $17 million. Year-over-year sales were up 1%, 5% and 2%, respectively; SOP was up 5%, 8% and 31%.
- SG&A was $552 million, down $2 million. Favorable foreign exchange ($6 million) and lower planned marketing investment ($4 million) were partly offset by higher compensation. The effective tax rate was 35.7%, versus 34.3%; the prior-year rate included a $2 million benefit from a New York State law change.
Cash, debt and liquidity
- Operating cash flow was $101 million; investing used $40 million, including $20 million of capital expenditure and a $15 million cost-method investment. Financing used $202 million, primarily for $135 million of share repurchases and $79 million of dividends.
- Total obligations were $2.617 billion at March 31, 2015, including $2.520 billion of senior unsecured notes and $97 million of capital leases. A $500 million note due January 2016 was classified as current. Cash was $93 million; the current ratio based on reported balances was approximately 0.77.
- No commercial paper or revolving-credit borrowings were outstanding. The $500 million revolver had $499 million available, and the company reported compliance with its financial covenants. The credit agreement’s maximum consolidated debt-to-annualized EBITDA covenant was 3.00 to 1.00.
- Management said operating cash flows should cover anticipated obligations for the next 12 months and intended to issue senior notes to refinance the $500 million 2016 notes before maturity. The company had $63 million of additional letters of credit outstanding under separate facilities.
Outlook, commentary and risks
- For 2015, management expected annual capital expenditures, net of disposals, of approximately 3% of net sales, funded from operating cash flow. No broader numerical earnings or sales guidance is provided in the supplied filing text.
- Management attributed the operating-cash-flow decline mainly to the timing of customer-incentive payments. It noted liquidity sensitivities including seasonality, continued dividends and repurchases, capital investment, access to commercial paper, and refinancing the 2016 notes.
- Key market exposures include foreign exchange, interest rates and commodities. The filing estimates that a 10% exchange-rate movement could change annual operating income by about $23 million; a 10% move in unhedged relevant commodity prices could change operating income by about $12 million for the remainder of 2015. Commodity derivatives had a net liability fair value of $27 million.
- The company reported no material change in the risk factors from its 2014 annual report. It said pending legal matters were not expected to have a material adverse effect, but an EPA Superfund-site investigation had undetermined remediation costs and no reasonable loss estimate; the company had paid approximately $750,000 toward its allocated study costs through quarter-end.
- The board authorized an additional $1 billion share-repurchase program in February 2015. The company repurchased 1.7 million shares for about $135 million during the quarter; $1.037 billion remained authorized. The declared quarterly dividend was $0.48 per share, a 17.1% increase over the prior dividend.
Important facts for investors to verify
- Confirm that this historical Dr Pepper Snapple Group filing is the intended issuer and period for the Keurig Dr Pepper request.
- Review the gross-margin decline and the extent to which mix and commodity-derivative comparisons may persist.
- Track the refinancing of the $500 million 2016 notes and any changes in cash, debt, covenant headroom or credit ratings.
- Assess whether operating cash flow recovers from the customer-incentive timing impact while supporting dividends, repurchases and planned capital spending.
- Monitor volume and segment trends, especially the contrast between strong Latin America volume growth and foreign-currency pressure, and the performance of Dr Pepper and other brands cited as declining.
- Check subsequent developments in the Superfund matter and the company’s commodity, currency and pension exposures.